Autophagy and mitophagy appear to be critical adaptive mechanisms for cardioprotection and mitigating adverse cardiac remodeling, highlighting their potential as therapeutic targets.
Answers are grounded in this paper and cite their sources.
Highlights autophagy pathways as potential HF therapy targets; leaves open clinical validation in prospective trials.
Whether an element of routine housekeeping or in the setting of imminent disaster, it is a good idea to get one's affairs in order. Autophagy, the process of recycling organelles and protein aggregates, is a basal homeostatic process and an evolutionarily conserved response to starvation and other forms of metabolic stress. Our understanding of the role of autophagy in the heart is changing rapidly as new information becomes available. This review examines the role of autophagy in the heart in the setting of cardioprotection, hypertrophy, and heart failure. Contradictory findings are reconciled in light of recent developments. The preponderance of evidence favors a beneficial role for autophagy in the heart under most conditions.
No takes yet. Share an insight, caveat, or question.
Gottlieb et al. (2012) conducted a review in Cardiovascular disease (ischemia-reperfusion injury, hypertrophy, heart failure). Autophagy and mitophagy was evaluated.
Synapse has enriched 10 related papers. Consider them for comparative context: